Richard Junghans
Physician · Cape Cod Healthcare
Credentials: · · · ·
History
- 2019–Present
- 1986–1989
- 1983–1986
Internal Medicine
Research
Proceedings of the National Academy of Sciences of the United States of America · 1996 · First of 2 authors · 551 citations
A humanized antibody that binds to the interleukin 2 receptor
Proceedings of the National Academy of Sciences of the United States of America · 1989 · 548 citations
A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin
Nature · 1989 · 401 citations
- TW
13 papers
12 papers · 1 as a resident
10 papers
- CN
4 papers
- LL
4 papers
- GS
3 papers
- JC
3 papers
2 papers
Grants
- 2020–2027
National Institute of Allergy and Infectious Diseases · R44
Contact PI · $3.3M · It Bio, Llc
- 2013–2016
Towards a New Clinical Trial Advanced Infection Proof Anti HIV Gene Modified T Ce
National Institute of Allergy and Infectious Diseases · R56
Contact PI · $400.2K · Tufts Medical Center
- 2007–2010
Potent Designer T Cells for HIV/AIDS Immunotherapy
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $466.2K · Roger Williams Hospital
- 2006–2010
Anti-Cea Designer t Cells in Gastric Cancer, Phase i Tr*
Food and Drug Administration · R01
Contact PI · $717.5K · Roger Williams Hospital
Clinical trials
- 2012–2017
Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas
Principal investigator · Suspended · Phase 2
Roger Williams Medical Center
- 2008–2018
Trial of 2nd Generation Anti-CEA Designer T Cells in Metastatic Breast Cancer
Principal investigator · Suspended · Phase 1
Roger Williams Medical Center
- 2008–2012
Trial of Second Generation Designer T Cells in Colorectal Carcinoma
Principal investigator · Terminated · Phase 1
Roger Williams Medical Center
- 2008–2018
Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
Principal investigator · Suspended · Phase 1
Roger Williams Medical Center